NCT00909831已完成1 期
A Phase I Trial of Hydroxychloroquine in Combination With Temsirolimus in Patients With Refractory Solid Tumors
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 40
- 试验地点
- 2
- 主要终点
- Maximum tolerated dose of hydroxychloroquine
研究概览
简要总结
RATIONALE: Drugs used in chemotherapy, such as hydroxychloroquine, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Temsirolimus may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving hydroxychloroquine together with temsirolimus may kill more tumor cells.
PURPOSE: This phase I trial is studying the side effects and best dose of hydroxychloroquine when given together with temsirolimus in treating patients with metastatic solid tumors that have not responded to treatment.
详细描述
OBJECTIVES:
Primary
- Determine the maximum tolerated dose of hydroxychloroquine (HCQ) in combination with temsirolimus (TEM) in patients with metastatic refractory solid tumors.
Secondary
- Describe the toxicity of this regimen in these patients.
- Measure the response rate in patients treated with this regimen.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 120 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Maximum tolerated dose of hydroxychloroquine
次要结局
- Response rate
- Toxicity rate as assessed by NCI CTCAE v. 3.0
- Pharmacokinetic and pharmacodynamic correlative endpoints
研究者
研究点 (2)
Loading locations...
相似试验
已完成
1 期
Hydroxychloroquine and Bortezomib in Treating Patients With Relapsed or Refractory Multiple MyelomaMultiple Myeloma and Plasma Cell NeoplasmNCT00568880Abramson Cancer Center at Penn Medicine25
已完成
1 期
Hydroxychloroquine and Temozolomide in Treating Patients With Metastatic or Unresectable Solid TumorsUnspecified Adult Solid Tumor, Protocol SpecificNCT00714181Abramson Cancer Center at Penn Medicine38
已完成
1 期
Hydroxychloroquine, Radiation, and Temozolomide Treating Patients With Newly Diagnosed Glioblastoma MultiformeBrain and Central Nervous System TumorsNCT00486603Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins92
终止
1 期
Phase I Study of Mitoxantrone and Etoposide Combined With Hydroxychloroquine, for Relapsed Acute Myelogenous LeukemiaLeukemia, Acute MyelogenousNCT02631252Alison Sehgal, MD, MS1
撤回
2 期
Evaluation of Hydroxychloroquine to Prevent CIPNBreast CancerGynecologic CancerEarly-stage Breast CancerChemotherapy-induced Peripheral NeuropathyPeripheral NeuropathyNCT05689359University of Arizona